Edgewell Personal Care Co's income statement, balance sheet and cash flow statement as filed with the SEC (10-K and 10-Q), with the latest fiscal years and quarters. In its latest fiscal year (Sep 30, 2025 · FY), Edgewell Personal Care Co reported revenue of $2.2B (-1.3% year on year) and net income of $25.4M (-74.2% year on year).
| Line item | Sep 30, 2025 · FY | Sep 30, 2024 · FY | Sep 30, 2023 · FY | Sep 30, 2022 · FY |
|---|---|---|---|---|
| Net sales | $2.2B | $2.3B | $2.3B | $2.2B |
| Cost of products sold | $1.3B | $1.3B | $1.3B | $1.3B |
| Gross profit | $924.9M | $955.7M | $940.8M | $879.4M |
| Selling, general and administrative expense | $425.0M | $430.1M | $409.6M | $389.1M |
| Advertising and sales promotion expense | $246.7M | $232.0M | $229.1M | $238.3M |
| Research and development expense | $57.6M | $58.4M | $58.5M | $55.5M |
| Restructuring charges | $47.9M | $35.9M | $16.6M | $15.3M |
| Goodwill, Impairment Loss | $51.1M | — | — | — |
| Operating income | $96.6M | $199.3M | $227.0M | $181.2M |
| Interest expense associated with debt | $73.2M | $76.5M | $78.5M | $71.4M |
| Other (income) expense, net | ($200.0K) | $1.9M | $800.0K | ($13.2M) |
| Earnings before income taxes | $23.6M | $120.9M | $147.7M | $123.0M |
| Income tax (benefit) provision | ($1.8M) | $22.3M | $33.0M | $24.4M |
| Basic | $0.53 | $1.98 | $2.24 | $1.86 |
| Diluted | $0.53 | $1.97 | $2.21 | $1.84 |
| Net earnings | $25.4M | $98.6M | $114.7M | $98.6M |
| Foreign currency translation adjustments | $27.0M | $18.6M | $44.3M | ($89.4M) |
| Pension and postretirement activity, net of tax | $17.2M | $1.2M | $6.6M | $4.7M |
| Deferred gain (loss) on hedging activity, net of tax | $800.0K | ($4.6M) | ($4.8M) | $5.5M |
| Total other comprehensive income (loss), net of tax | $45.0M | $15.2M | $46.1M | ($79.2M) |
| Total comprehensive income | $70.4M | $113.8M | $160.8M | $19.4M |
| Basic weighted-average shares outstanding (in shares) | 47.5M | — | — | — |
| Diluted weighted-average shares outstanding (in shares) | 47.6M | — | — | — |
| Line item | Jun 30, 2026 · Q3 | Mar 31, 2026 · Q2 | Dec 31, 2025 · Q1 | Jun 30, 2025 · Q3 |
|---|---|---|---|---|
| Net sales | $570.1M | $519.5M | $422.8M | $627.2M |
| Cost of products sold | $327.6M | $302.6M | $261.8M | $358.7M |
| Gross profit | $242.5M | $216.9M | $161.0M | $268.5M |
| Selling, general and administrative expense | $108.3M | $111.0M | $102.4M | $104.4M |
| Advertising and sales promotion expense | $83.2M | $58.6M | $45.6M | $80.4M |
| Research and development expense | $13.3M | $14.9M | $13.8M | $14.0M |
| Restructuring charges | $12.7M | $14.0M | $18.1M | $16.0M |
| Operating Income (Loss) | $25.0M | $18.4M | ($18.9M) | $53.7M |
| Interest expense associated with debt | $16.7M | $17.9M | $19.3M | $19.4M |
| Other income, net | ($9.7M) | ($7.4M) | ($1.3M) | ($2.9M) |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | $18.0M | $7.9M | ($36.9M) | $37.2M |
| Income tax provision on continuing operations | $5.7M | $3.9M | ($7.7M) | $8.1M |
| Continuing operations | $0.30 | -$0.23 | -$1.41 | $0.62 |
| Discontinued operations | $0.29 | -$0.22 | -$1.41 | $0.62 |
| Net earnings (loss) | $13.7M | ($10.6M) | ($65.7M) | $29.1M |
| Foreign currency translation adjustments | ($1.6M) | ($12.0M) | $3.2M | $53.5M |
| Pension and postretirement activity | $400.0K | $300.0K | $600.0K | $500.0K |
| Deferred gain (loss) on hedging activity, net of tax | $1.1M | $1.2M | $1.5M | ($3.7M) |
| Total other comprehensive income (loss), net of tax | ($100.0K) | ($10.5M) | $5.3M | $50.3M |
| Total comprehensive income (loss) | $13.6M | ($21.1M) | ($60.4M) | $79.4M |
| Basic weighted-average shares outstanding (in shares) | 46.1M | 46.5M | 46.6M | 46.8M |
| Diluted weighted-average shares outstanding (in shares) | 46.6M | 46.8M | 46.6M | 47.0M |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent | $12.3M | $4.0M | ($29.2M) | — |
| Income (Loss) from Continuing Operations, Per Basic Share | $0.27 | $0.09 | ($0.63) | — |
| Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Basic Share | $0.03 | ($0.32) | ($0.78) | — |
| Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | $1.4M | ($14.6M) | ($36.5M) | — |
| Income (Loss) from Continuing Operations, Per Diluted Share | $0.26 | $0.09 | ($0.63) | — |
| Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Diluted Share | $0.03 | ($0.31) | ($0.78) | — |
| Line item | Sep 30, 2025 · FY | Sep 30, 2024 · FY | Sep 30, 2023 · FY | Sep 30, 2022 · FY |
|---|---|---|---|---|
| Cash and cash equivalents | $225.7M | $209.1M | $216.4M | $188.7M |
| Trade receivables | $137.8M | $109.4M | $106.2M | $136.9M |
| Inventory, Net | $484.7M | $477.3M | $492.4M | $449.3M |
| Other current assets | $147.3M | $140.2M | $147.4M | $167.3M |
| Total current assets | $995.5M | $936.0M | $962.4M | $942.2M |
| Property, Plant and Equipment, Net | $369.3M | $349.1M | $337.9M | $345.5M |
| Goodwill | $1.3B | $1.3B | $1.3B | $1.3B |
| Other intangible assets, net | $921.3M | $948.5M | $973.8M | $996.6M |
| Other assets | $179.1M | $158.7M | $135.2M | $106.6M |
| Total assets | $3.8B | $3.7B | $3.7B | $3.7B |
| Notes payable | $29.5M | $24.5M | $19.5M | $19.0M |
| Accounts payable | $219.7M | $219.3M | $194.4M | $237.3M |
| Other current liabilities | $316.3M | $319.8M | $309.5M | $291.7M |
| Total current liabilities | $565.5M | $563.6M | $523.4M | $548.0M |
| Long-term debt | $1.4B | $1.3B | $1.4B | $1.4B |
| Deferred income tax liabilities | $118.8M | $133.2M | $136.4M | $140.4M |
| Other liabilities | $135.6M | $175.0M | $179.7M | $173.6M |
| Total liabilities | $2.2B | $2.1B | $2.2B | $2.3B |
| Common shares | 700.0K | 700.0K | 700.0K | 700.0K |
| Additional paid-in capital | $1.6B | $1.6B | $1.6B | $1.6B |
| Retained earnings | $1.1B | $1.1B | $1.0B | $931.7M |
| Common shares in treasury at cost | -1.0B | -937.9M | -906.1M | -860.9M |
| Accumulated other comprehensive loss | ($109.8M) | ($154.8M) | ($170.0M) | ($216.1M) |
| Total shareholders’ equity | $1.6B | $1.6B | $1.5B | $1.5B |
| Total liabilities and shareholders’ equity | $3.8B | $3.7B | $3.7B | $3.7B |
| Common shares, par value (in usd per share) | $0.01 | — | — | — |
| Common shares, issued (in shares) | 65.3M | — | — | — |
| Common shares, outstanding (in shares) | 46.5M | — | — | — |
| Common shares, authorized (in shares) | 300.0M | — | — | — |
| Treasury shares (in shares) | 18.8M | — | — | — |
| Preferred shares, authorized (in shares) | 10.0M | — | — | — |
| Preferred shares, par value (in usd per share) | $0.01 | — | — | — |
| Preferred shares, outstanding (in shares) | 0 | — | — | — |
| Line item | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Jun 30, 2025 |
|---|---|---|---|---|
| Cash and cash equivalents | $397.1M | $299.7M | $223.3M | $199.6M |
| Trade receivables | $119.4M | $185.4M | $154.0M | $153.2M |
| Inventory, Net | $433.0M | $450.1M | $461.2M | $488.4M |
| Other current assets | $162.5M | $174.3M | $161.6M | $163.5M |
| Disposal Group, Including Discontinued Operation, Assets, Current | $0 | $0 | $57.0M | — |
| Total current assets | $1.1B | $1.1B | $1.1B | $1.0B |
| Property, Plant and Equipment, Net | $292.7M | $289.5M | $292.5M | $355.7M |
| Goodwill | $1.1B | $1.1B | $1.1B | $1.3B |
| Other intangible assets, net | $806.4M | $813.4M | $821.8M | $929.3M |
| Other assets | $190.3M | $186.2M | $179.1M | $160.7M |
| Disposal Group, Including Discontinued Operation, Assets, Noncurrent | $0 | $0 | $280.0M | — |
| Total assets | $3.5B | $3.5B | $3.8B | $3.8B |
| Notes payable | $34.2M | $35.1M | $32.5M | $23.2M |
| Accounts payable | $230.7M | $231.1M | $213.1M | $224.5M |
| Other current liabilities | $338.7M | $347.6M | $247.9M | $319.7M |
| Disposal Group, Including Discontinued Operation, Liabilities, Current | $0 | $0 | $4.0M | — |
| Total current liabilities | $603.6M | $613.8M | $497.5M | $567.4M |
| Long-term debt | $1.2B | $1.2B | $1.5B | $1.4B |
| Deferred income tax liabilities | $79.6M | $80.2M | $118.3M | $133.7M |
| Other liabilities | $147.3M | $146.7M | $145.1M | $151.5M |
| Total liabilities | $2.1B | $2.1B | $2.3B | $2.2B |
| Preferred shares | 0 | 0 | 0 | — |
| Common shares | 700.0K | 700.0K | 700.0K | 700.0K |
| Additional paid-in capital | $1.6B | $1.6B | $1.6B | $1.6B |
| Retained earnings | $1.0B | $995.8M | $1.0B | $1.1B |
| Common shares in treasury at cost | -997.5M | -997.8M | -984.6M | -1.0B |
| Accumulated other comprehensive loss | ($115.1M) | ($115.0M) | ($104.5M) | ($126.9M) |
| Total shareholders’ equity | $1.5B | $1.4B | $1.5B | $1.6B |
| Total liabilities and shareholders’ equity | $3.5B | $3.5B | $3.8B | $3.8B |
| Common shares, par value (in usd per share) | $0.01 | — | — | $0.01 |
| Common shares, issued (in shares) | 65.3M | — | — | 65.3M |
| Common shares, outstanding (in shares) | 46.1M | — | — | 46.5M |
| Common shares, authorized (in shares) | 300.0M | — | — | 300.0M |
| Treasury shares (in shares) | 19.2M | — | — | 18.8M |
| Preferred shares, authorized (in shares) | 10.0M | — | — | 10.0M |
| Preferred shares, par value (in usd per share) | $0.01 | — | — | $0.01 |
| Line item | Sep 30, 2025 · FY | Sep 30, 2024 · FY | Sep 30, 2023 · FY | Sep 30, 2022 · FY |
|---|---|---|---|---|
| Net earnings | $25.4M | $98.6M | $114.7M | $98.6M |
| Depreciation, Depletion and Amortization | $88.8M | $88.0M | $91.4M | $89.9M |
| Goodwill, Impairment Loss | $51.1M | — | — | — |
| Share-based compensation expense | $24.5M | $26.5M | $27.5M | $23.8M |
| Deferred income taxes | ($21.7M) | ($9.6M) | ($4.5M) | ($13.7M) |
| Deferred compensation payments | ($3.1M) | ($2.1M) | ($4.9M) | ($7.3M) |
| Defined benefit settlement loss | $1.9M | $700.0K | $2.5M | $1.5M |
| Defined benefit settlement loss | $0 | $0 | ($7.9M) | — |
| Other, net | ($22.7M) | ($18.7M) | ($23.5M) | ($9.8M) |
| Increase (Decrease) in Accounts Receivable | $15.3M | ($7.3M) | $31.0M | ($6.6M) |
| Increase (Decrease) in Inventories | $100.0K | $19.7M | ($32.4M) | ($111.3M) |
| Increase (Decrease) in Other Current Assets | $2.6M | $4.7M | $20.8M | ($11.5M) |
| Increase (Decrease) in Accounts Payable, Trade | $3.3M | $17.0M | ($30.2M) | $30.4M |
| Increase (Decrease) in Other Current Liabilities | ($11.3M) | $13.5M | $15.8M | $18.0M |
| Cash Provided by (Used in) Operating Activity, Including Discontinued Operation, Total | $118.4M | $231.0M | $216.1M | $102.0M |
| Payments to Acquire Productive Assets | $77.0M | ($56.5M) | ($49.5M) | ($56.4M) |
| Proceeds from Collection of Retained Interest in Securitized Receivables | $5.6M | $700.0K | $2.7M | $6.9M |
| Payment for (Proceeds from) Other Investing Activity | $1.5M | ($6.6M) | ($3.7M) | ($1.5M) |
| Cash Provided by (Used in) Investing Activity, Including Discontinued Operation, Total | ($72.9M) | ($62.4M) | ($50.5M) | ($355.4M) |
| Proceeds from Long-Term Lines of Credit | $931.0M | $813.0M | $841.0M | $707.0M |
| Repayments of Long-Term Lines of Credit | $825.0M | ($901.0M) | ($874.0M) | ($552.0M) |
| Proceeds from (Repayments of) Short-Term Debt, Maturing in Three Months or Less | $5.5M | $4.2M | $0 | ($3.9M) |
| Payments for Repurchase of Common Stock | $90.2M | ($58.5M) | ($75.2M) | ($125.3M) |
| Payments of Dividends | $29.3M | ($30.7M) | ($31.5M) | ($32.6M) |
| Payment, Tax Withholding, Share-Based Payment Arrangement | $7.5M | ($7.3M) | ($9.0M) | ($10.7M) |
| Proceeds from (Repayments of) Accounts Receivable Securitization | ($14.1M) | $5.2M | $2.3M | — |
| Other, net | ($400.0K) | ($4.3M) | ($100.0K) | $700.0K |
| Cash Provided by (Used in) Financing Activity, Including Discontinued Operation, Total | ($30.0M) | ($179.4M) | ($146.5M) | ($17.6M) |
| Cash and cash equivalents, beginning | $209.1M | $216.4M | $188.7M | $479.2M |
| Cash and cash equivalents, ending | $225.7M | $209.1M | $216.4M | $188.7M |
| Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation | $1.1M | $3.5M | $8.6M | ($19.5M) |
| Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation, Total | $16.6M | ($7.3M) | $27.7M | ($290.5M) |
| Cash paid for interest, net | $73.3M | $62.8M | $74.3M | $68.4M |
| Cash paid for income taxes, net | $25.5M | $33.5M | $45.8M | $23.8M |
| Line item | Jun 30, 2026 · YTD | Mar 31, 2026 · YTD | Dec 31, 2025 · Q1 | Jun 30, 2025 · YTD |
|---|---|---|---|---|
| Net Income (Loss) | ($62.6M) | ($76.3M) | ($65.7M) | $56.0M |
| Depreciation, Depletion and Amortization | $59.0M | $40.4M | $21.3M | $65.6M |
| Goodwill, Impairment Loss | ($2.2M) | $2.2M | $3.8M | — |
| Share-Based Payment Arrangement, Noncash Expense | $14.7M | $9.0M | $3.4M | $18.8M |
| Deferred Income Taxes and Tax Credits | ($39.8M) | ($39.2M) | ($900.0K) | ($500.0K) |
| Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Other Item | $8.3M | $10.9M | $12.5M | ($12.2M) |
| Cash Provided by (Used in) Operating Activity, Including Discontinued Operation, Total | $47.1M | ($71.6M) | ($125.9M) | $44.3M |
| Payments to Acquire Productive Assets | $41.2M | ($25.6M) | ($11.6M) | ($49.4M) |
| Proceeds from Collection of Retained Interest in Securitized Receivables | $3.3M | $1.8M | $1.7M | $5.6M |
| Payment for (Proceeds from) Other Investing Activity | $0 | $0 | — | ($1.5M) |
| Cash Provided by (Used in) Investing Activity, Including Discontinued Operation, Total | $301.0M | $315.1M | ($9.9M) | ($45.3M) |
| Proceeds from Long-Term Lines of Credit | $398.0M | $398.0M | $292.0M | $774.0M |
| Repayments of Long-Term Lines of Credit | $538.0M | ($538.0M) | ($155.0M) | ($678.0M) |
| Proceeds from (Repayments of) Short-Term Debt, Maturing in Three Months or Less | $3.1M | $4.6M | $2.4M | ($800.0K) |
| Payments for Repurchase of Common Stock | $15.8M | ($15.8M) | $0 | ($90.2M) |
| Payments of Dividends | $21.5M | ($14.5M) | ($7.4M) | ($22.4M) |
| Payment, Tax Withholding, Share-Based Payment Arrangement | ($2.9M) | ($2.8M) | ($2.8M) | ($7.4M) |
| Proceeds from (Repayments of) Accounts Receivable Securitization | $2.7M | $1.2M | $4.3M | $14.2M |
| Proceeds from (Payment for) Other Financing Activity | ($300.0K) | ($100.0K) | ($100.0K) | ($300.0K) |
| Cash Provided by (Used in) Financing Activity, Including Discontinued Operation, Total | ($174.7M) | ($167.4M) | $133.4M | ($10.9M) |
| Cash and cash equivalents, beginning | $225.7M | $225.7M | $225.7M | $209.1M |
| Cash and cash equivalents, ending | $397.1M | — | — | — |
| Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation | ($2.0M) | ($2.1M) | $0 | $2.4M |
| Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation, Total | $171.4M | $74.0M | ($2.4M) | ($9.5M) |
| Gain (Loss) on Disposition of Other Assets | $1.4M | $1.1M | $0 | $1.7M |
| Goodwill, Impairment Loss | $37.4M | $37.4M | — | — |
| Increase (Decrease) in Other Operating Assets and Liabilities, Net | $28.8M | ($55.1M) | ($137.5M) | ($82.7M) |
| Increase (Decrease) in Deferred Compensation | ($2.3M) | ($2.0M) | ($200.0K) | ($2.4M) |
| Proceeds from Divestiture of Businesses | $338.9M | $338.9M | — | — |
Edgewell Personal Care Co score and earnings-call analysis · All covered companies
Figures as reported in SEC filings. General information, not investment advice.